Form Bio Information

Form Bio is advancing genome engineering for cell and gene therapy applications with an integrated, AI-powered platform that connects computational design, wet-lab validation, manufacturing intelligence, and genomic quality control to help developers optimize therapeutic constructs, identify potential manufacturing challenges earlier, and improve product quality. Form Bio’s integrated platform includes: FormSightAI™: An AI-powered computational platform for genetic medicine and vector design, enabling developers to design and optimize therapeutic constructs in silico. FormLab: Integrated wet-lab validation services that connect computational design with experimental data to validate and optimize genetic medicine candidates. FormBatchQC™: Genomic quality and comparability analytics that assess genome integrity, detect and quantify impurities and contaminants, and evaluate lot-to-lot consistency. FormManufacturing™: An end-to-end platform for designing, optimizing, and monitoring manufacturability from initial construct design through scale-up. Together, these capabilities create a connected development workflow in which biological performance, genome integrity, product quality, and manufacturability can be evaluated earlier, while design decisions remain more flexible. By identifying potential issues, including unwanted genomic material and manufacturing-related impurities, developers can make more informed decisions to refine constructs, improve quality, and reduce downstream risk. Customer programs have demonstrated up to 8× improvement in genome integrity, 2–3× higher manufacturing yield, and 5× improvement in controllable expression. By connecting AI-powered design with experimental validation, manufacturing insights, and genomic quality analytics, Form Bio helps developers reduce risk, optimize outcomes, and accelerate the path from discovery to the clinic.